In the phase 2 NEJM trial, participants receiving the highest dose of retatrutide (12 mg) achieved a mean body weight reduction of approximately 24.2% from baseline at 48 weeks, compared with approximately 2.1% in the placebo group
Data analysed by paired two-tailed Students t-test ( j - m ), unpaired two-tailed Students t-test ( p and r ), one-way ANOVA, multiple comparison, Bonferroni post hoc test ( h ) and two-way repeated measures ANOVA to assess main effects of treatment ( c , d and s - v )
Clean Ingredients: Avoid products with synthetic fillers, artificial dyes, or unnecessary additives
Ipamorelin may increase appetite due to its action on the ghrelin receptor, which is known to stimulate hunger
H.QuyyumiA
Several mechanisms may explain why some patients experience tiredness while taking GLP-1 receptor agonists